- Report
- January 2024
- 200 Pages
Global
From €4804EUR$5,000USD£4,131GBP
- Report
- March 2023
- 89 Pages
Asia Pacific
From €1441EUR$1,500USD£1,239GBP
- Report
- March 2022
- 87 Pages
Global
From €3500EUR$3,902USD£3,115GBP
- Report
- May 2024
- 50 Pages
Global
From €2546EUR$2,650USD£2,189GBP
Penciclovir is an antiviral drug used to treat infections caused by certain types of viruses. It is primarily used to treat herpes simplex virus (HSV) infections, including genital herpes, cold sores, and shingles. It is also used to treat varicella zoster virus (VZV) infections, such as chickenpox and shingles. Penciclovir is available in both topical and oral forms.
Penciclovir is a member of the nucleoside analog antiviral drug class, which works by blocking the replication of viral DNA. It is generally well tolerated, with few side effects. It is not effective against other types of viruses, such as influenza or HIV.
Penciclovir is used in the treatment of infectious diseases, including HSV and VZV infections. It is also used to prevent recurrent HSV infections. It is available in both generic and brand-name formulations.
In the penciclovir market, some of the major players include GlaxoSmithKline, Novartis, Mylan, and Teva Pharmaceuticals. Other companies in the market include Sandoz, Actavis, and Sun Pharmaceuticals. Show Less Read more